Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03856099
Title TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors PharmAbcine
Age Groups: senior | adult
Covered Countries USA | AUS

No variant requirements are available.